Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing SCAI-001 to Restasis for dry eye syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndromes

Drugs mentioned

• Restasis (Cyclosporine A)
• SCAI-001

Snippet

Sponsor: SCAI Therapeutics | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED